Cargando…
Apremilast Use for Moderate-to-Severe Atopic Dermatitis in Pediatric Patients
Atopic dermatitis (AD) is a chronic, pruritic skin disease often complicated by bacterial superinfection affecting 10.7% of American children. The pathogenesis involves a skin barrier breakdown in addition to dysfunctional innate and adaptive immune response, including an unbalanced increase in T-he...
Autores principales: | Saporito, Rachael C., Cohen, David J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965536/ https://www.ncbi.nlm.nih.gov/pubmed/27504087 http://dx.doi.org/10.1159/000446836 |
Ejemplares similares
-
Worsening of Lymphopenia during Apremilast Treatment
por: Kolios, Antonios G.A., et al.
Publicado: (2016) -
Recurrence of Melanoma after Starting Apremilast for Psoriasis
por: Salopek, Thomas G.
Publicado: (2017) -
Atopic Dermatitis as a Paradoxical Effect of Secukinumab for the Treatment of Psoriasis
por: Mendes Roncada, Eduardo V., et al.
Publicado: (2021) -
Apremilast Is Effective in Lichen Planus Mucosae-Associated Stenotic Esophagitis
por: Hafner, Jürg, et al.
Publicado: (2016) -
Pseudotumor of the Larynx: A Previously Unreported Side Effect of Apremilast
por: Ntouniadakis, Eleftherios, et al.
Publicado: (2020)